Search Results - "Lino, J."
-
1
Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia
Published in American journal of obstetrics and gynecology (01-02-2022)“…There has been increasing research momentum to identify new therapeutic agents for the prevention or treatment of preeclampsia, drugs that can affect the…”
Get full text
Journal Article -
2
Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction
Published in American journal of obstetrics and gynecology (01-03-2016)“…Background Preeclampsia is associated with placental ischemia/hypoxia and secretion of soluble fms-like tyrosine kinase 1 and soluble endoglin into the…”
Get full text
Journal Article -
3
Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia
Published in Hypertension (Dallas, Tex. 1979) (01-09-2015)“…Preeclampsia is a major pregnancy complication where excess placental release of soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin causes…”
Get full text
Journal Article -
4
Using the methylome to predict pre-eclampsia
Published in Nature medicine (01-09-2023)“…A blood test done in early pregnancy that measures cell-free DNA methylation could represent a novel way to predict the risk of preterm pre-eclampsia…”
Get full text
Journal Article -
5
Quantitative Point of Care Tests for Timely Diagnosis of Early‐Onset Preeclampsia with High Sensitivity and Specificity
Published in Angewandte Chemie International Edition (26-06-2023)“…Preeclampsia is a heterogeneous and multiorgan cardiovascular disorder of pregnancy. Here, we report the development of a novel strip‐based lateral flow assay…”
Get full text
Journal Article -
6
Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia
Published in PloS one (11-04-2018)“…Preeclampsia is one of the most serious complications of pregnancy. Currently there are no medical treatments. Given placental oxidative stress may be an early…”
Get full text
Journal Article -
7
Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia
Published in PloS one (21-02-2018)“…The discovery of new treatments that prevent or treat preeclampsia would be a major advance. Antiangiogenic factors soluble fms-like tyrosine kinase-1 (sFlt-1)…”
Get full text
Journal Article -
8
EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion
Published in Hypertension (Dallas, Tex. 1979) (01-03-2019)“…Preeclampsia is a hypertensive disorder of pregnancy characterized by maternal endothelial dysfunction and end-organ damage. The antiangiogenic factor, sFlt-1…”
Get full text
Journal Article -
9
Repurposing existing drugs as a therapeutic approach for the prevention of preterm birth
Published in Reproduction (Cambridge, England) (01-01-2023)“…In brief Preterm birth is the leading cause of perinatal morbidity and mortality; however, current therapies offer limited efficacy to delay birth and improve…”
Get full text
Journal Article -
10
Investigating the Effects of Atrial Natriuretic Peptide on the Maternal Endothelium to Determine Potential Implications for Preeclampsia
Published in International journal of molecular sciences (24-03-2023)“…Preeclampsia is associated with an increased lifelong risk of cardiovascular disease (CVD). It is not clear whether this is induced by persistent systemic…”
Get full text
Journal Article -
11
Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction
Published in Nature communications (15-05-2020)“…Placental insufficiency can cause fetal growth restriction and stillbirth. There are no reliable screening tests for placental insufficiency, especially…”
Get full text
Journal Article -
12
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
Published in Scientific reports (12-05-2017)“…Preeclampsia is a disease of pregnancy associated with placental oxidative stress, inflammation and elevated release of anti-angiogenic factors sFlt-1 and…”
Get full text
Journal Article -
13
Investigating ticagrelor in a preclinical pipeline as a novel therapeutic to prevent preterm birth
Published in Reproduction (Cambridge, England) (01-03-2024)“…Preterm birth is the leading cause of perinatal morbidity and mortality, and new therapies that delay preterm birth and improve neonatal outcomes are urgently…”
Get full text
Journal Article -
14
Controlling eutrophication by means of water recirculation: An optimal control perspective
Published in Journal of computational and applied mathematics (15-03-2023)“…In this work, the artificial recirculation of water is presented and analyzed, from the perspective of the optimal control of partial differential equations,…”
Get full text
Journal Article -
15
Clinical tools and biomarkers to predict preeclampsia
Published in EBioMedicine (01-01-2022)“…Preeclampsia is pregnancy-specific, and significantly contributes to maternal, and perinatal morbidity and mortality worldwide. An effective predictive test…”
Get full text
Journal Article -
16
Plasma metabolites are altered before and after diagnosis of preeclampsia or fetal growth restriction
Published in Scientific reports (09-07-2024)“…Metabolomics is the study of small molecules (metabolites), within cells, tissues and biofluids. Maternal metabolites can provide important insight into the…”
Get full text
Journal Article -
17
Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease
Published in International journal of molecular sciences (01-09-2022)“…Previously, we demonstrated that the proton pump inhibitor, esomeprazole magnesium hydrate (MH), could have potential as a repurposed treatment against…”
Get full text
Journal Article -
18
Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth
Published in Scientific reports (06-04-2023)“…Spontaneous preterm birth is the leading cause of perinatal morbidity and mortality. Tocolytics are drugs used in cases of imminent preterm birth to inhibit…”
Get full text
Journal Article -
19
Serum Collected from Preeclamptic Pregnancies Drives Vasoconstriction of Human Omental Arteries-A Novel Ex Vivo Model of Preeclampsia for Therapeutic Development
Published in International journal of molecular sciences (16-09-2022)“…New-onset maternal hypertension is a hallmark of preeclampsia, driven by widespread endothelial dysfunction and systemic vasoconstriction. Here, we set out to…”
Get full text
Journal Article -
20
Circulating Chemerin Is Elevated in Women With Preeclampsia
Published in Endocrinology (Philadelphia) (01-05-2023)“…Abstract Background: Preeclampsia is a severe complication of pregnancy. Chemerin is an adipokine secreted from adipose tissue and highly expressed in…”
Get full text
Journal Article